Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Israel-based biotechnology company Oramed Pharmaceuticals has received the patent from the Japanese patent office for its technology in oral delivery of proteins.
Subscribe to our email newsletter
The patent, titled "Methods and Compositions for Oral Administrations of Proteins," covers a core concept of the company’s technology.
Oramed CEO Nadav Kidron said, "The Japanese patent approval represents a great success in further establishing the global standing of Oramed’s innovative oral delivery technology."
The patent has also been approved in Israel and Australia, according to the company.
Currently Oramed’s portfolio consists of seven issued patents and 28 pending patents.